Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 1-8 of 8 (Search time: 0.002 seconds).
  • previous
  • 1
  • next
Item hits:
PreviewIssue DateTitleAuthor(s)
2013Mass or molar? Recommendations for reporting concentrations of therapeutic drugsJones, G.; Bryant, S.; Fullinfaw, R.; Ilett, K.; Miners, J.; Morris, R.; Doogue, M.
2011Measurement of Cyclosporine A in rat tissues and human kidney transplant biopsies - A method suitable for small (<1 mg) samplesNoll, B.; Coller, J.; Somogyi, A.; Morris, R.; Russ, G.; Hesselink, D.; van Gelder, T.; Sallustio, B.
2011Comparison of blood sirolimus, tacrolimus and everolimus concentrations measured by LC-MS/MS, HPLC-UV and immunoassay methodsSallustio, B.; Noll, B.; Morris, R.
2010Current status of therapeutic drug monitoring in Australia and New Zealand: A need for improved assay evaluation, best practice guidelines, and professional developmentNorris, R.; Martin, J.; Thompson, E.; Ray, J.; Fullinfaw, R.; Joyce, D.; Barras, M.; Jones, G.; Morris, R.
2010Frequently discordant results from therapeutic drug monitoring for digoxin: clinical confusion for the prescriberRogers, N.; Jones, T.; Morris, R.
2013Validation of an LC-MS/MS method to measure tacrolimus in rat kidney and liver tissue and its application to human kidney biopsiesNoll, B.; Coller, J.; Somogyi, A.; Morris, R.; Russ, G.; Hesselink, D.; van Gelder, T.; Sallustio, B.
2010Does liquid chromatography-tandem mass spectrometry have a role in therapeutic drug monitoring of digoxin?Taylor, P.; Morris, R.
2016Therapeutic drug monitoring of everolimus: a consensus reportShipkova, M.; Hesselink, D.; Holt, D.; Billaud, E.; Van Gelder, T.; Kunicki, P.; Brunet, M.; Budde, K.; Barten, M.; De Simone, P.; Wieland, E.; Lopez, O.; Masuda, S.; Seger, C.; Picard, N.; Oellerich, M.; Langman, L.; Wallemacq, P.; Morris, R.; Thompson, C.; et al.